Display options
Share it on

J Clin Med. 2014 Sep 18;3(3):1043-9. doi: 10.3390/jcm3031043.

Actual Therapeutic Indication of an Old Drug: Urea for Treatment of Severely Symptomatic and Mild Chronic Hyponatremia Related to SIADH.

Journal of clinical medicine

Guy Decaux, Fabrice Gankam Kengne, Bruno Couturier, Frédéric Vandergheynst, Wim Musch, Alain Soupart

Affiliations

  1. Departments of Internal Medicine, Erasmus University Hospital, Route de Lennik, 808, Brussels B-1070, Belgium. [email protected].
  2. Departments of Nephrology, Erasmus University Hospital, Brussels B-1070, Belgium. [email protected].
  3. Departments of Internal Medicine, Erasmus University Hospital, Route de Lennik, 808, Brussels B-1070, Belgium. [email protected].
  4. Departments of Internal Medicine, Erasmus University Hospital, Route de Lennik, 808, Brussels B-1070, Belgium. [email protected].
  5. Department of Internal Medicine, Bracops Hospital, Brussels B-1070, Belgium. [email protected].
  6. Departments of Internal Medicine, Erasmus University Hospital, Route de Lennik, 808, Brussels B-1070, Belgium. [email protected].
  7. Department of Internal Medicine, Jolimont/Tubize Hospital, Tubize 1480, Belgium. [email protected].

PMID: 26237492 PMCID: PMC4449637 DOI: 10.3390/jcm3031043

Abstract

Oral urea has been used in the past to treat various diseases like gastric ulcers, liver metastases, sickle cell disease, heart failure, brain oedema, glaucoma, Meniere disease, etc. We have demonstrated for years, the efficacy of urea to treat euvolemic (SIADH) or hypervolemic hyponatremia. We briefly describe the indications of urea use in symptomatic and paucisymptomatic hyponatremic patients. Urea is a non-toxic, cheap product, and protects against osmotic demyelinating syndrome (ODS) in experimental studies. Prospective studies showing the benefit to treat mild chronic hyponatremia due to SIADH and comparing water restriction, urea, high ceiling diuretics, and antivasopressin antagonist antagonist should be done.

Keywords: ODS; SIADH; V2 antagonist; high ceiling diuretics; hyponatremia; urea

References

  1. Scand Audiol. 1977;6(3):143-6 - PubMed
  2. Crit Care. 2010;14(5):R184 - PubMed
  3. Clin J Am Soc Nephrol. 2012 May;7(5):742-7 - PubMed
  4. Ir J Med Sci. 1968 Jun;7(6):243-53 - PubMed
  5. J Urol. 1994 Feb;151(2):401-3 - PubMed
  6. Nephrol Dial Transplant. 2007 Jul;22(7):1856-63 - PubMed
  7. Brain Res. 2000 Jan 3;852(1):167-72 - PubMed
  8. Br Med J. 1957 Oct 19;2(5050):906-11 - PubMed
  9. Nephron. 1986;44(4):337-43 - PubMed
  10. Am J Physiol. 1962 Oct;203:739-47 - PubMed
  11. J Neurosurg. 1989 Feb;70(2):201-6 - PubMed
  12. JAMA. 1982 Jan 22-29;247(4):471-4 - PubMed
  13. Lancet. 2008 May 10;371(9624):1624-32 - PubMed
  14. Acta Clin Belg. 2000 Mar-Apr;55(2):68-78 - PubMed
  15. Am J Med Sci. 1971 Jun;261(6):325-34 - PubMed
  16. Kidney Int. 2009 Sep;76(6):614-21 - PubMed
  17. Nephron. 1983;35(2):82-8 - PubMed
  18. Surg Clin North Am. 1958 Aug;38(4):907-28 - PubMed
  19. Medicine (Baltimore). 1990 May;69(3):153-9 - PubMed
  20. Clin Sci (Lond). 1989 Sep;77(3):351-5 - PubMed
  21. Br Med J (Clin Res Ed). 1985 Jun 15;290(6484):1782-3 - PubMed
  22. J Neuropathol Exp Neurol. 1996 May;55(5):594-601 - PubMed
  23. Nephron Clin Pract. 2012;120(3):c168-72 - PubMed
  24. Kidney Int. 2015 Feb;87(2):323-31 - PubMed
  25. Br Med J (Clin Res Ed). 1981 Oct 24;283(6299):1081-3 - PubMed
  26. Br J Cancer. 1988 Mar;57(3):317-8 - PubMed
  27. Clin Sci. 1964 Oct;27:223-7 - PubMed
  28. Eur J Endocrinol. 2014 Feb 25;170(3):G1-47 - PubMed
  29. J Am Soc Nephrol. 2002 Jun;13(6):1433-41 - PubMed
  30. Int J Cardiol. 1987 Oct;17(1):102-4 - PubMed
  31. Clin Sci (Lond). 1991 Jan;80(1):77-84 - PubMed
  32. Can Med Assoc J. 1962 Jan 6;86:17-21 - PubMed
  33. Am J Med. 1980 Jul;69(1):99-106 - PubMed

Publication Types